Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 

    Article Cited by others


Imatinib mesylate resistance and mutations: An Indian experience

Srivastava Shweta, Dutt Sarjana

Year : 2013| Volume: 34| Issue : 3 | Page no: 213-220

   This article has been cited by
1 Chronic Myeloid Leukemia - Prognostic Value of Mutations
Bushra Kaleem,Sadaf Shahab,Nuzhat Ahmed,Tahir Sultan Shamsi
Asian Pacific Journal of Cancer Prevention. 2015; 16(17): 7415
[Pubmed]  [Google Scholar] [DOI]
2 Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India
Sailaja Kagita,Srihari Uppalapati,Sangeeta Jiwatani,Vijay Gandhi Linga,Sadasivudu Gundeti,Narayana Nagesh,Raghunadharao Digumarti
Tumor Biology. 2014;
[Pubmed]  [Google Scholar] [DOI]
3 Will kinase domain mutations dictate the terms...
Agarwal, M., Rathi, S.
Indian Journal of Medical and Paediatric Oncology. 2013; 34(3): 151-153
[Pubmed]  [Google Scholar]


Read this article